Skip to main content
TipRanks
Go Ultimate75% OFF

ImmuPharma (25I) Q2 2026 Earnings Report

0 Followers

DE:25I Q2 2026 EPS Results

Actual EPS
-EUR 0.01
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.00

DE:25I Q2 2026 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2026
Date
09/15/2026
Time
Before Open
Conference Call
Tuesday, September 15, 2026
DE:25I Upcoming Earnings

ImmuPharma's next earnings date is estimated for May 25, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:25I Earnings History

DE:25I earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 25, 20272026 (Q4)―-0――
Sep 15, 20262026 (Q2)―-0.010-100.00% (-0.00)
May 27, 20262025 (Q4)―0.00-0.01100.00% (+0.01)
Aug 06, 20252025 (Q2)―-0.000-300.00% (-0.00)
May 19, 20252024 (Q4)―-0.01――
Sep 09, 20242024 (Q2)―-0.00050.00% (+0.00)
Jun 05, 20242023 (Q4)―--0.01―
Aug 31, 20232023 (Q2)―-0.00-0.0166.67% (+0.00)
May 11, 20232022 (Q4)―-0.01-0.0261.11% (+0.01)
Sep 30, 20222022 (Q2)―-0.01-0.0260.00% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed